4-methyl-2-[(2R)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]piperazin-1-yl]-1,3-thiazole
C13H20F3N3OS — CID 98761299
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methyl-2-[(2R)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]piperazin-1-yl]-1,3-thiazole
4-methyl-2-[(2R)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]piperazin-1-yl]-1,3-thiazole (PubChem CID 98761299) has the molecular formula C13H20F3N3OS and a molecular weight of 323.38 g/mol. Its IUPAC name is 4-methyl-2-[(2R)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]piperazin-1-yl]-1,3-thiazole.
Molecular Properties
| Compound Name | 4-methyl-2-[(2R)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]piperazin-1-yl]-1,3-thiazole |
|---|---|
| PubChem CID | 98761299 |
| Molecular Formula | C13H20F3N3OS |
| Molecular Weight | 323.38 g/mol |
| Exact Mass | 323.13 |
| IUPAC Name | 4-methyl-2-[(2R)-2-methyl-4-[2-(2,2,2-trifluoroethoxy)ethyl]piperazin-1-yl]-1,3-thiazole |
| SMILES | Cc1csc(N2CCN(CCOCC(F)(F)F)C[C@H]2C)n1 |
| InChI | InChI=1S/C13H20F3N3OS/c1-10-8-21-12(17-10)19-4-3-18(7-11(19)2)5-6-20-9-13(14,15)16/h8,11H,3-7,9H2,1-2H3/t11-/m1/s1 |
| InChIKey | VKPWTTOHEINZGZ-LLVKDONJSA-N |
| XLogP | 2.54 |
| TPSA | 28.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 323.38 |
| LogP ≤ 5 | 2.54 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 98761299 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.